Leymus Genomics ApS: Financial statements 2021
CVR: 38106872
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Leymus Genomics ApS (CVR 38106872) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 6,081,520 and a net result of DKK 3,044,086 compared with DKK 347,192 the year before. That is an increase of 907.4% compared with the year before. Equity in the 2021 report amounted to DKK 3,682,235. The solvency ratio was 66.1%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 6,081,520
- Profit/Loss
- DKK 3,044,086
- Equity
- DKK 3,682,235
- Total Assets
- DKK 5,567,858
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 6.1M | 3M | 3.7M | 4 |
| 2020 | - | 604K | 347K | 638K | 1 |
| 2019 | - | -156K | -370K | 291K | - |
| 2018 | - | -186K | -228K | 161K | - |
Official annual report
Find more companies like Leymus Genomics ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Leymus Genomics ApS has published its annual report for 2020. Gross profit came to DKK 603,688, and the net result was DKK 347,192.
About Leymus Genomics ApS
Leymus Genomics ApS was a Danish company of the type Anpartsselskab based in Herlev, founded in 2016. The company has been dissolved on 28 November 2024. The company was registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named Leymus Scientific Capital ApS. The company has 3 employees (2023). In 2023, the company reported a gross profit of DKK -1,341,461 and a net result of DKK -1,269,016 compared with DKK -1,655,772 the year before. Equity in the 2023 report amounted to DKK -124,553.